BioWorld Science

RSS

Phase II LIBERTY study of ubenimex in PAH does not meet primary endpoint

Jan. 17, 2018

Abide Therapeutics gives an overview of their serine hydrolase-targeting products

Jan. 17, 2018

AvantGen begins second cancer therapeutic antibody discovery program with Tanabe Research Labs

Jan. 17, 2018

Final results reported from phase II study of Bekinda in IBS-D

Jan. 17, 2018

Context Therapeutics acquires Apristor from Arno Therapeutics

Jan. 17, 2018

Gamida Cell commences phase I study of NAM-NK cells in NHL and MM

Jan. 17, 2018

Rxi Pharmaceuticals to focus on immuno-oncology

Jan. 17, 2018

FDA accepts Ruconest sBLA for review

Jan. 17, 2018

U.S. priority review and E.U. accelerated assessment granted for Kymriah

Jan. 17, 2018

Jounce Therapeutics reviews its next-generation immunotherapy pipeline

Jan. 17, 2018